Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. - Wikidata - awgldk - TriplyDB

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

http://www.wikidata.org/entity/Q35037837

about

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics Treatment of nonalcoholic fatty liver disease: role of AMPK.Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes Unraveling the Paradox of Selective Insulin Resistance in the Liver: the Brain-Liver Connection Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial.ChREBP regulates fructose-induced glucose production independently of insulin signaling.Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice.Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus.Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4.Insights into the Hexose Liver Metabolism-Glucose versus Fructose Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver.A mathematical model of the impact of insulin secretion dynamics on selective hepatic insulin resistance.Targeting viperin improves diet-induced glucose intolerance but not adipose tissue inflammation.Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation.Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes.Pak1 mediates the stimulatory effect of insulin and curcumin on hepatic ChREBP expression.Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Growth Hormone Control of Hepatic Lipid Metabolism.Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis.Methods for quantifying adipose tissue insulin resistance in overweight/obese humans.Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate.Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of Pparg2 expression.Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.Usp25m protease regulates ubiquitin-like processing of TUG proteins to control GLUT4 glucose transporter translocation in adipocytes.Potential adverse effects of botanical supplementation in high-fat-fed female mice

P2860

Q26752583-046C910E-5395-4E6D-9799-70C7B6188391 Q26796668-A65CF502-5ADE-4F0E-960C-B40299CF0F00 Q30248230-05360470-4410-4768-9FF8-FF08903187D4 Q33794679-A6A697DB-00A8-4364-8D9F-EBA2215038E0 Q34533119-ECF80D2A-6408-4A4E-A1CE-506E9641B1BA Q34543004-094040D7-DBAA-486E-A430-D739DE3C357F Q36430696-FD4A29A8-A09C-48AA-A75F-F58AAB152F62 Q36570916-6ECA9726-52F5-4827-A896-167F6C314D5A Q36607551-C9CAB90B-2032-40CD-A0AA-CAA346E5E54A Q36930783-1926146C-FB3B-430C-A539-2BBCB845F559 Q36953626-37B0C426-6C68-4C56-B97C-4A2472BD16EF Q37139415-E503C0A7-7D44-4670-BEB5-5CC9EC423FDC Q37394470-354ECBD3-65A3-4716-A962-59DFE3149EA9 Q37395843-1A8F7634-AB33-418B-AB36-2CADC1026263 Q37628330-5F109416-38E5-4917-A73A-3201A8D4B1DE Q39306199-0B6AD07C-C822-4BBE-B465-435C75498950 Q39393326-CB984581-00AD-4B36-B747-60226246D14F Q39818267-8033276E-695C-43D4-A5BE-0516A22527C2 Q41673841-4F93BF40-A119-4D7E-8710-DCB1C29F74DA Q42284517-D3F037E7-380D-4F38-857D-0863C9C4330D Q46368143-25C18341-2A7E-4EFB-9314-BB1A39D78935 Q46775808-D4959E78-EF68-400F-B1E7-0F83AD5899DD Q47161195-91C326FC-D19E-4C9E-B89A-30DF885C9DC5 Q47200958-773ACA22-8CD5-4F89-9428-F5AFD503E8E6 Q47610898-0017A080-39C3-426C-9D5F-52EF807AC651 Q47676910-7BBD8FB4-BD85-4832-B8D6-11E41A39412C Q47779219-5440174A-508C-4417-96B0-4D83CEC11493 Q49329608-444C48D2-E768-480E-82A9-2E68AF54E2C6 Q50018586-DAA75A56-7753-4F34-B49F-41C2CACF74FE Q50206048-8563997A-1379-4BE7-AAA0-E376F5CE6CFD Q51267452-8866D016-71C7-4F6E-8365-9F2F9F873258 Q51597934-6405FC0B-BDA0-486A-8A2A-1DECC30C36A3 Q52880767-48E90F4F-DDEA-4A07-AF30-1EF2D29F3D29 Q53083755-BB15E2C4-7EC0-443E-827C-F2779A57635F Q53801131-F50B47E9-72F6-4FE9-AEFE-E36CCB3D7EF2 Q54109024-1679CF69-5781-447E-906A-7F6B1614E2C9 Q58748438-8B2F0C0E-8F18-49A6-9A0E-AED9A580D64A

P2860

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

http://www.wikidata.org/entity/Q35037837

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

@ast

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

@en

type

label

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

@ast

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

@en

prefLabel

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

@ast

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

@en

P1433

Q35037837-4B8A3F36-2390-4B68-B188-D6C24E147F54

P1476

Q35037837-7FAFD640-F571-4325-B003-850E1080BB94

P2093

Q35037837-110DAB27-53C9-4FB8-A67E-7B29CD19B8FE

Q35037837-1B50D4B1-C639-457F-B8E4-7274BC519EA2

Q35037837-2007D0A9-1E2B-41F0-94BD-5AFBB80AB722

Q35037837-2C921996-73FF-4982-B272-9EFC9C4A8F52

Q35037837-4D6E93BF-5DE7-48E2-9762-83E3BED62DDD

Q35037837-6B2709F0-BE0B-4193-A226-81B2394E4A64

Q35037837-8A346E36-AFFC-437C-A81A-2CF339980FED

Q35037837-A072656A-ABAD-4702-A1A1-18D57755E7BA

Q35037837-A2CBE167-8306-4A41-89F5-2A4FB4EE0737

Q35037837-E24D84BC-721E-4DC4-88C8-3F4037D22DA0

P2860

Q35037837-0559AAF6-2292-4E81-8620-F14EAFE788C0

Q35037837-072C7D51-DFDF-4DB1-99EE-4B200F3FA78B

Q35037837-0AA19D8E-CA9B-4411-8F64-6BC2FB9B4800

Q35037837-0B1258AF-6CA6-4726-9FCB-AD84CD24346B

Q35037837-0CC01FF9-D7AB-43A3-9F22-7114BD449ACD

Q35037837-123BE250-E9D5-4174-99CB-CE20838D46EE

Q35037837-1A68345F-832F-4B0A-BE93-52CE56D24A16

Q35037837-1CC51D70-473C-4284-B5C5-B1D431AA9EDE

Q35037837-22DF13A5-16F8-4BA2-A9E0-F3670868FA8F

Q35037837-291FA36D-3B4B-469F-B1E1-B3ACBEF08ECA

P304

Q35037837-A1EE6F28-35CB-4659-8B52-AD50ED41BA20

P31

Q35037837-650D3104-246F-4E1C-BA40-B5E1719900E5

P356

Q35037837-9A133BA6-6D48-4EB7-BFE8-04C424462606

P407

Q35037837-43ABB365-1B7A-461E-9921-78E30A5AEB14

P433

Q35037837-1D056613-1925-418B-99EE-99E6285E4235

P478

Q35037837-BDE7801C-C0EA-4CBE-9DE7-406880899D8F

P50

Q35037837-65928E1B-A114-462C-A73E-39E6B280567E

Q35037837-6D1A6845-2F45-4457-95BA-43C4718FD3FA

P577

Q35037837-8C45BAD6-A443-484E-8689-05BFFAB8B950

P5875

Q35037837-F4F28D71-7DE7-414E-B133-BCD02258A236

P698

Q35037837-BC41EDFF-D5CB-4974-B8B1-8761BC9DFF68

P921

Q35037837-509F7C0A-CB47-42D7-8A65-BACCD3F09D45

Q35037837-D490E553-4140-40F6-87EE-64C5DE1FA26A

Q35037837-E175EC14-076F-439B-88F6-12D7DC0D8C0A

P932

Q35037837-BFD2B6B6-C4F1-4661-B6DB-F5AB71C57B97

P356

PNAS.1423952112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids

@en

P2093

Arijeet K Gattu

http://www.w3.org/2001/XMLSchema#string

Daniel F Vatner

http://www.w3.org/2001/XMLSchema#string

Gary W Cline

http://www.w3.org/2001/XMLSchema#string

João-Paulo G Camporez

http://www.w3.org/2001/XMLSchema#string

Max C Petersen

http://www.w3.org/2001/XMLSchema#string

Mitchell Bears

http://www.w3.org/2001/XMLSchema#string

Naoki Kumashiro

http://www.w3.org/2001/XMLSchema#string

Sachin K Majumdar

http://www.w3.org/2001/XMLSchema#string

Varman T Samuel

http://www.w3.org/2001/XMLSchema#string

Yasmeen Rahimi

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Mechanisms for insulin resistance: common threads and missing links

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism

A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice.

P304

1143-1148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1423952112

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Jurczak

Gerald I. Shulman

P577

2015-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270654140

http://www.w3.org/2001/XMLSchema#string

P698

25564660

http://www.w3.org/2001/XMLSchema#string

P921

P932

4313795

http://www.w3.org/2001/XMLSchema#string